ATE458746T1 - Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs - Google Patents
Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebsInfo
- Publication number
- ATE458746T1 ATE458746T1 AT01938945T AT01938945T ATE458746T1 AT E458746 T1 ATE458746 T1 AT E458746T1 AT 01938945 T AT01938945 T AT 01938945T AT 01938945 T AT01938945 T AT 01938945T AT E458746 T1 ATE458746 T1 AT E458746T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer chemotherapeutics
- melphalan
- melphalan derivatives
- derivatives
- alkylating
- Prior art date
Links
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical class OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 title abstract 2
- 230000001093 anti-cancer Effects 0.000 title 1
- 230000002152 alkylating effect Effects 0.000 abstract 2
- 150000003862 amino acid derivatives Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000000711 cancerogenic effect Effects 0.000 abstract 1
- 231100000315 carcinogenic Toxicity 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21122700P | 2000-06-13 | 2000-06-13 | |
| SE0002202A SE0002202D0 (sv) | 2000-06-13 | 2000-06-13 | New peptides |
| PCT/SE2001/001318 WO2001096367A1 (en) | 2000-06-13 | 2001-06-11 | Melphalan derivatives and their use as cancer chemotherapeutic drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE458746T1 true ATE458746T1 (de) | 2010-03-15 |
Family
ID=20280067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01938945T ATE458746T1 (de) | 2000-06-13 | 2001-06-11 | Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1290011B1 (de) |
| JP (1) | JP4798930B2 (de) |
| AT (1) | ATE458746T1 (de) |
| AU (1) | AU2001264515A1 (de) |
| CA (1) | CA2408501C (de) |
| DK (1) | DK1290011T3 (de) |
| ES (1) | ES2341702T3 (de) |
| PT (1) | PT1290011E (de) |
| SE (1) | SE0002202D0 (de) |
| WO (1) | WO2001096367A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1374907A3 (de) * | 2002-06-24 | 2004-01-07 | Ghanem Elias c/o Institut Jules Bordet Ghanem | Arzneimittel Transport und Abgabesystem |
| DE10239832A1 (de) * | 2002-08-29 | 2004-03-18 | Lipal Biochemicals AG c/o University of Zurich | Sarcolysyl-Derivate und Verfahren zu deren Herstellung |
| WO2011011865A1 (en) * | 2009-07-29 | 2011-02-03 | 3R Valo, S.E.C. | Anticancer agents based on amino acid derivatives |
| WO2011078782A1 (en) * | 2009-12-22 | 2011-06-30 | Oncopeptides Ab | A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer |
| RS56462B1 (sr) | 2011-04-28 | 2018-01-31 | Oncopeptides Ab | Liofilizovani preparat citotoksičnih dipeptida |
| PT3228319T (pt) * | 2011-04-28 | 2020-08-27 | Oncopeptides Ab | Preparação liofilizada de dipéptidos citotóxicos |
| DK2928463T3 (da) * | 2012-10-26 | 2020-02-24 | Oncopeptides Ab | Lyofiliserede præparater af melphalan-flufenamid |
| JP6284945B2 (ja) | 2012-10-26 | 2018-02-28 | オンコペプティデス エービーＯｎｃｏｐｅｐｔｉｄｅｓ ＡＢ | メルファランフルフェナミドの凍結乾燥製剤 |
| GB201507903D0 (en) * | 2015-05-08 | 2015-06-24 | Oncopeptides Ab | Process for preparation of nitrogen mustard derivatives |
| GB201521217D0 (en) | 2015-12-01 | 2016-01-13 | Oncopeptides Ab | Dosage regimens |
| CN108864251B (zh) * | 2018-06-30 | 2022-06-14 | 大连理工大学 | 一类氨肽酶n激活的药物前体化合物及其制备方法和应用 |
| AU2019362389B2 (en) * | 2018-10-18 | 2024-12-12 | Oncopeptides Innovation Ab | Compounds containing deuterium |
| CN114025753A (zh) | 2019-04-03 | 2022-02-08 | 肿瘤多肽有限公司 | 用美氟芬治疗al淀粉样变性 |
| GB201905477D0 (en) * | 2019-04-17 | 2019-05-29 | Oncopeptides Ab | Novel formulations |
| WO2021053185A1 (en) | 2019-09-20 | 2021-03-25 | Oncopeptides Ab | Melflufen formulations and their use in the treatment or prophylaxis of osteosarcoma |
| WO2022167087A1 (en) * | 2021-02-05 | 2022-08-11 | Oncopeptides Ab | Peptidase enhanced cytotoxic dipeptides |
| EP4083052A1 (de) | 2021-04-29 | 2022-11-02 | BKmdcl AB | Peptidkonjugate von melphalan zur behandlung von krebs |
| US20240270680A1 (en) | 2021-06-01 | 2024-08-15 | Synthon B.V. | Process for making melflufen or a salt thereof |
| EP4366721A1 (de) | 2021-07-08 | 2024-05-15 | Oncopeptides Innovation AB | Melflufen zur verwendung bei der behandlung von multiplem myelom |
| GB202109896D0 (en) | 2021-07-08 | 2021-08-25 | Oncopeptides Ab | Novel treatments |
| GB202109894D0 (en) | 2021-07-08 | 2021-08-25 | Oncopeptides Ab | Novel treatments |
| GB202109895D0 (en) | 2021-07-08 | 2021-08-25 | Oncopeptides Ab | Novel treatments |
| GB202204171D0 (en) | 2022-03-24 | 2022-05-11 | Oncopeptides Ab | Novel formulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB750155A (en) | 1953-03-17 | 1956-06-13 | Nat Res Dev | Substituted alanines |
-
2000
- 2000-06-13 SE SE0002202A patent/SE0002202D0/xx unknown
-
2001
- 2001-06-11 CA CA2408501A patent/CA2408501C/en not_active Expired - Lifetime
- 2001-06-11 ES ES01938945T patent/ES2341702T3/es not_active Expired - Lifetime
- 2001-06-11 WO PCT/SE2001/001318 patent/WO2001096367A1/en not_active Ceased
- 2001-06-11 JP JP2002510508A patent/JP4798930B2/ja not_active Expired - Lifetime
- 2001-06-11 AT AT01938945T patent/ATE458746T1/de not_active IP Right Cessation
- 2001-06-11 DK DK01938945.1T patent/DK1290011T3/da active
- 2001-06-11 AU AU2001264515A patent/AU2001264515A1/en not_active Abandoned
- 2001-06-11 EP EP01938945A patent/EP1290011B1/de not_active Expired - Lifetime
- 2001-06-11 PT PT01938945T patent/PT1290011E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE0002202D0 (sv) | 2000-06-13 |
| JP2004503564A (ja) | 2004-02-05 |
| WO2001096367A1 (en) | 2001-12-20 |
| CA2408501C (en) | 2011-01-18 |
| AU2001264515A1 (en) | 2001-12-24 |
| ES2341702T3 (es) | 2010-06-25 |
| PT1290011E (pt) | 2010-05-11 |
| DK1290011T3 (da) | 2010-06-07 |
| CA2408501A1 (en) | 2001-12-20 |
| JP4798930B2 (ja) | 2011-10-19 |
| EP1290011A1 (de) | 2003-03-12 |
| EP1290011B1 (de) | 2010-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE458746T1 (de) | Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
| ECSP10010265A (es) | Sales farmaceuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8 dihidro-9h-purin-9-il)propil](3-morfolin-4 ilpropil)amino]metil}fenil) | |
| BRPI0407922A (pt) | derivados de isoquinolina e métodos de uso destes | |
| BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| PT1041072E (pt) | Acidos dioxociclopentil hidroxamicos | |
| UY27755A1 (es) | Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores. | |
| WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
| CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
| CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
| BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
| TR200401793T4 (tr) | Perindopril tuzu ve bunu içeren farmasötik bileşimler. | |
| CL2007002619A1 (es) | Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion. | |
| CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
| ATE451916T1 (de) | Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat | |
| LU92202I2 (fr) | Aflibercept | |
| CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
| CY1110401T1 (el) | Παραγωγα των 1-φαινυλαλκανοκαρβοξυλικων οξεων για την αντιμετωπιση των νευροεκφυλιστικων νοσων | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| DE602005019416D1 (de) | Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid | |
| WO2002030964A3 (en) | Comparative ligand mapping from mhc positive cells | |
| CY1108711T1 (el) | Συνθεσεις βενζοθειαζολιου και η χρηση αυτων | |
| EP1896588A4 (de) | Neues a -bindungsprotein und dessen peptidderivate sowie verwendungen davon | |
| IS2849B (is) | Notkun á írbesartani til framleiðslunnar á lyfjum sem eru notuð til að fyrirbyggja eða meðhöndla lungnaháþrýsting |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |